{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:41:10Z","timestamp":1775493670561,"version":"3.50.1"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this article is to draw attention to the role of Epstein\u2013Barr virus (EBV) virus in the pathogenesis of the primary Sj\u00f6gren's syndrome. The article introduces the problem of consequences of EBV acute infection, and its reactivation, in association with the immune response modulation by the virus and with an increased risk of developing systemic autoimmune diseases and EBV-associated cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The knowledge about the mechanisms by which the virus may stay for years in a latent phase, unrecognized by the host response immune cells is constantly expanding. There are several mechanisms and theories about EBV influence on the autoimmune process in Sjogren's syndrome (pSS), including the similarity (molecular mimicry) between viral EBNA-2 protein and Ro-60 antigen or EBER-1 and EBER-2 viral proteins and La antigen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The influence of EBV infection on the development and course of pSS has been proven. It has also been established that both EBV and pSS result in the increased risk of tumor (especially lymphoma) development. In the light of these findings, new ways to manage EBV infections are being sought. Optimal methods for assessing EBV infection status are being devised. Research also aims at finding therapies, which target EBV through the inhibition of the autoimmune process and of viral activity. The present article is an attempt to discuss the most important phenomena and elements linking EBV infection to the primary Sj\u00f6gren's syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000622","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T13:43:46Z","timestamp":1564407826000},"page":"475-483","source":"Crossref","is-referenced-by-count":69,"title":["The role of Epstein\u2013Barr virus infection in primary Sj\u00f6gren's syndrome"],"prefix":"10.1097","volume":"31","author":[{"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.arcmed.2006.08.002","article-title":"Pathophysiology of Sj\u00f6gren's syndrome","volume":"37","author":"Garc\u00eda-Carrasco","year":"2006","journal-title":"Arch Med Res"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar3348","article-title":"Disturbance of cytokine networks in Sj\u00f6gren's syndrome","volume":"13","author":"Youinou","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R3-20230829","first-page":"e584","article-title":"Sjogren's syndrome: review of the aetiology, pathophysiology & potential therapeutic interventions","volume":"9","author":"Nair","year":"2017","journal-title":"J Clin Exp Dent"},{"key":"R4-20230829","first-page":"191","article-title":"Charakterystyka bia\u0142ek wirusa Epsteina-Barr \u2013 ich udzia\u0142 w zaka\u017ceniu latentnym i powi\u0105zanie z procesami nowotworzenia","volume":"51","author":"\u017buk-Wasek","year":"2012","journal-title":"Post Mikrobiol"},{"key":"R5-20230829","first-page":"286","article-title":"Zaka\u017cenia EBV-cykl \u017cyciowy, metody diagnostyki, chorobotw\u00f3rczo\u015b\u0107. Post\u0119py Hig","volume":"65","author":"Bocian","year":"2011","journal-title":"Med Do\u015bw"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"R7-20230829","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/03009740310004676","article-title":"Estimating the prevalence among Caucasian women of primary Sj\u00f6gren's syndrome in two general practices in Birmingham, UK","volume":"33","author":"Bowman","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/ar599","article-title":"Genetic aspects of Sj\u00f6gren's syndrome","volume":"4","author":"Bolstad","year":"2002","journal-title":"Arthritis Res"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"e111991","DOI":"10.1371\/journal.pone.0111991","article-title":"A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene","volume":"9","author":"Ciccacci","year":"2014","journal-title":"PLoS One"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/art.24662","article-title":"The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sj\u00f6gren's syndrome","volume":"60","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jdermsci.2010.06.011","article-title":"Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjogren's syndrome","volume":"59","author":"Yin","year":"2010","journal-title":"J Dermatol Sci"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2013.00142","article-title":"The Interferon-signature of Sj\u00f6gren's syndrome: how unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases","volume":"4","author":"Nguyen","year":"2013","journal-title":"Front Immunol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sj\u00f6gren's syndrome: results of a large multicentre study","volume":"44","author":"Quartuccio","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.bor.0000135450.78047.78","article-title":"Apoptosis and estrogen deficiency in primary Sj\u00f6gren syndrome","volume":"16","author":"Hayashi","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"75","DOI":"10.33590\/emjrheumatol\/10313472","article-title":"Primary Sj\u00f6gren's syndrome in the elderly: does age of onset makes a difference?","volume":"5","author":"Manzo","year":"2018","journal-title":"EMJ Rheumatol"},{"key":"R20-20230829","first-page":"198","article-title":"Phenotyping Sj\u00f6gren's syndrome: towards a personalised management of the disease","volume":"36 Suppl 112","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20230829","first-page":"427","article-title":"Juvenile Sj\u00f6gren syndrome: distinctive age, unique findings","volume":"34","author":"de Souza","year":"2012","journal-title":"Pediatr Dent"},{"key":"R22-20230829","first-page":"213","article-title":"Genetic and environmental factors of atopy","volume":"51","author":"Akiko","year":"2008","journal-title":"Allergol Intl"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2222.2001.00996.x","article-title":"A shadow of Epstein-Barr virus in the pathogenesis of atopic diseases","volume":"31","author":"Okudaira","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"e85387","DOI":"10.1371\/journal.pone.0085387","article-title":"Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome","volume":"9","author":"Loebel","year":"2014","journal-title":"PLoS One"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mehy.2004.01.012","article-title":"Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?","volume":"62","author":"Staines","year":"2004","journal-title":"Med Hypotheses"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2016.04.070","article-title":"Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels","volume":"474","author":"Phan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2015.11.007","article-title":"Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L","volume":"69","author":"Lindsey","year":"2015","journal-title":"Mol Immunol"},{"issue":"(Suppl 1)","key":"R28-20230829","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10428190802311417","article-title":"Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas","volume":"49","author":"Cohen","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/JCM.39.9.3164-3170.2001","article-title":"Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138","volume":"39","author":"Dardari","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/mp.53.5.238","article-title":"The expression and function of Epstein-Barr virus encoded latent genes","volume":"53","author":"Young","year":"2000","journal-title":"Mol Pathol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.7150\/ijbs.19531","article-title":"Pathogenic role of exosomes in Epstein-Barr virus (EBV)-associated cancers","volume":"13","author":"Teow","year":"2017","journal-title":"Int J Biol Sci"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ebiom.2016.06.041","article-title":"Targeting the Ca (2+) sensor STIM1 by exosomal transfer of Ebv-miR-BART13-3p is associated with Sj\u00f6gren's syndrome","volume":"10","author":"Gallo","year":"2016","journal-title":"EBioMedicine"},{"key":"R33-20230829","first-page":"1046","article-title":"Epstein-Barr virus DNA in serum\/plasma as a tumor marker for nasopharyngeal cancer","volume":"6","author":"Shotelersuk","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Practice Res Clin Rheumatol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"18083","DOI":"10.1038\/srep18083","article-title":"A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1\u22171501 on risk of multiple sclerosis","volume":"5","author":"Xiao","year":"2015","journal-title":"Sci Rep"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.4049\/jimmunol.137.10.3162","article-title":"Detection of Epstein-Barr virus associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome","volume":"137","author":"Fox","year":"1986","journal-title":"J Immunol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.78.2.805","article-title":"Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus","volume":"78","author":"Lerner","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar4429","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus","volume":"16","author":"Hanlon","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R41-20230829","first-page":"647","article-title":"Antibodies to viral citrullinated peptide in rheumatoid arthritis","volume":"33","author":"Anzilotti","year":"2006","journal-title":"J Rheumatol"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2010-04-278218","article-title":"T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies","volume":"117","author":"Shaffer","year":"2011","journal-title":"Blood"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol"},{"key":"R44-20230829","first-page":"e1004906","article-title":"Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8+ T cells","volume":"11","author":"Rancan","year":"2015","journal-title":"PLoSPathog"},{"key":"R45-20230829","first-page":"189096","article-title":"CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmune Dis"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/10408363.2015.1094443","article-title":"Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer","volume":"53","author":"Sarkar","year":"2015","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.2002.1716","article-title":"Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV","volume":"304","author":"Salek-Ardakani","year":"2002","journal-title":"Virology"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2005.09.021","article-title":"Identification of tear lipocalin as a novel autoantigen target in Sj\u00f6gren's syndrome","volume":"25","author":"Navone","year":"2005","journal-title":"J Autoimmun"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/cancers10040098","article-title":"The immunomodulatory capacity of an Epstein-Barr virus abortive lytic cycle: potential contribution to viral tumorigenesis","volume":"10","author":"Morales-S\u00e1nchez","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","article-title":"Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review","volume":"51","author":"Kivity","year":"2014","journal-title":"J Autoimmun"},{"issue":"(Suppl 10)","key":"R52-20230829","article-title":"Not only Sj\u00f6gren's syndrome. EBV infection reactivation as a risk factor of the dryness symptome development [abstract]","volume":"67","author":"Ma\u015bli\u0144ska","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0004-27492013000200016","article-title":"Dry eye disease caused by viral infection: review","volume":"76","author":"Alves","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1038\/s41467-018-07308-5","article-title":"Vasculogenic mimicry formation in EBV-associated epithelial malignancies","volume":"9","author":"Xiang","year":"2018","journal-title":"Nat Commun"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/ijms18081606","article-title":"The role of epigenetic regulation in Epstein-Barr virus-associated gastric cancer","volume":"18","author":"Nishikawa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7150\/ijbs.25018","article-title":"Salivary exosomes: emerging roles in systemic disease","volume":"14","author":"Han","year":"2018","journal-title":"Int J Biol Sci"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.rdc.2016.03.004","article-title":"The proteomics of saliva in Sj\u00f6gren's syndrome","volume":"42","author":"Katsiougiannis","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fonc.2019.00104","article-title":"Progress in EBV vaccines","volume":"9","author":"van Zyl","year":"2019","journal-title":"Front Oncol"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-981-10-7230-7_22","article-title":"Vaccine development for Epstein-Barr virus","volume":"1045","author":"Cohen","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1158\/1535-7163.MCT-05-0253","article-title":"Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas","volume":"4","author":"Israel","year":"2005","journal-title":"Mol Cancer Ther"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:06:50Z","timestamp":1693292810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000622","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}